India's Central Drugs Standard Control Organisation (CDSCO) recently granted approval to pharmaceutical majors Cipla Limited and Optimus Pharma Limited to conduct Phase IV trials for Favipiravir, the most sought-after medicine in the treatment of mild to moderate symptoms of COVID-19.
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×Contact Us
For More Info!
